-
Sector Analysis
NewVietnam Telecom Operators Country Intelligence Report
Vietnam Telecom Operators Country Intelligence Overview The total telecom service revenue in Vietnam reached $6.4 billion in 2023. The market size growth has been estimated to incline at a CAGR of more than 4% during 2023-2028. This growth will be supported by a spike in mobile data and fixed broadband service segments. Also, the National Digital Transformation Program - 2025 aimed at speeding up digital transformation by changing business strategies and providing incentives to encourage enterprises, government administration, and manufacturing...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Lennox-Gastaut Syndrome Drug Details: JBPOS-0101 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Dravet Syndrome (Severe Myoclonic Epilepsy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Alzheimer's Disease Drug Details: JBPOS-0101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Post Partum Depression (Maternal Depression / Postnatal Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Post Partum Depression (Maternal Depression / Postnatal Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Post Partum Depression (Maternal...
-
Sector Analysis
mRNA Vaccines in Infectious Diseases Market Outlook and Trends by Opportunities, Challenges, Unmet Needs, and Competitive Landscape
mRNA Vaccines in Infectious Diseases Market Report Overview The first mRNA vaccines for COVID-19 gained authorization for use in December 2020. These vaccines have been proven highly successful clinically and commercially, dominating the COVID-19 vaccine market. Furthermore, the success of the COVID-19 mRNA vaccines has renewed interest in mRNA vaccines for a variety of other infectious diseases such as influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), Mpox, herpes, Zika virus, and Lyme disease. The report provides an assessment of the...
-
Track & Monitor
Covid-19 in pharma: COVID recombinant spike proteins
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s COVID recombinant spike proteins segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1083 in Influenza A Virus, H1N1 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1083 in Influenza A Virus, H1N1 Subtype Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-1083 in Influenza A Virus, H1N1 Subtype Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1083 in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1083 in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-1083 in Influenzavirus B Infections Drug Details: mRNA-1083 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1083 in Influenza A Virus, H3N2 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1083 in Influenza A Virus, H3N2 Subtype Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-1083 in Influenza A Virus, H3N2 Subtype Infections...